Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment - ScienceDirect

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment - ScienceDirect: Androgen receptor (AR) antagonists, such as enzalutamide, have had a major impact on the treatment of metastatic castration-resistant prostate cancer …

Comments

Popular posts from this blog

Dr. Christopher Kane of UCSD Health Appointed Chairman of the American Board of Urology

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily